Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.

S'inscrire

PSTX Poseida Therapeutics Inc

2,85

0,20 (7,55%)

22 Juin 2024 - Fermé

Retardé de 15 minutes

Biotech Soars on Research Collaboration And License Agreement Release

A California-based biotech company is turning heads on Wednesday after it announced that it entered into a research collaboration and license agreement with Astellas...

To read the full story on AllPennyStocks.com, click here.

Poseida Therapeutics (NASDAQ:PSTX)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024

Plus de graphiques de la Bourse Poseida Therapeutics

Poseida Therapeutics (NASDAQ:PSTX)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024

Plus de graphiques de la Bourse Poseida Therapeutics

Actualités Poseida Therapeutics Inc

Form 4 - Statement of changes in beneficial ownership of securities
Mardi 18 Juin 2024 ( il y a 4 jours) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mardi 18 Juin 2024 ( il y a 4 jours) • Edgar (US Regulatory)

Form 8-K - Current report
Mardi 18 Juin 2024 ( il y a 4 jours) • Edgar (US Regulatory)

Poseida Therapeutics Announces Virtual 2024 Annual Meeting of Stockholders
Lundi 3 Juin 2024 ( il y a 3 semaines) • PR Newswire (US)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mardi 14 Mai 2024 ( il y a 1 mois) • Edgar (US Regulatory)

Form 8-K - Current report
Mardi 14 Mai 2024 ( il y a 1 mois) • Edgar (US Regulatory)

Poseida Therapeutics Provides Updates and Financial Results for the First Quarter of 2024
Mardi 14 Mai 2024 ( il y a 1 mois) • PR Newswire (US)

Poseida Highlights Strong Progress on Its Genetic Medicine Programs at the American Society for Gene and Cell Therapy 27th Annual Meeting
Jeudi 9 Mai 2024 ( il y a 1 mois) • PR Newswire (US)

Form EFFECT - Notice of Effectiveness
Lundi 6 Mai 2024 ( il y a 2 mois) • Edgar (US Regulatory)

Astellas and Poseida Therapeutics Enter Into Research Collaboration and License Agreement to Develop Novel Allogeneic Cell Therapies in Oncology
Jeudi 2 Mai 2024 ( il y a 2 mois) • PR Newswire (US)

Biotech Soars on Research Collaboration And License Agreement Release
Mercredi 1 Mai 2024 ( il y a 2 mois) • AllPennyStocks.com

Astellas and Poseida Therapeutics Enter Into Research Collaboration and License Agreement to Develop Novel Allogeneic Cell Therapies in Oncology
Mercredi 1 Mai 2024 ( il y a 2 mois) • PR Newswire (US)

Plus d'articles sur Poseida Therapeutics Inc

Agency Group Australia

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales